{"id":79265,"date":"2024-09-26T19:41:29","date_gmt":"2024-09-26T17:41:29","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=customer-stories&p=79265"},"modified":"2026-05-20T16:29:51","modified_gmt":"2026-05-20T14:29:51","slug":"simplifying-to-speed-up-time-to-patient","status":"publish","type":"customer-stories","link":"https:\/\/pantheon.veeva.com\/eu\/customer-stories\/simplifying-to-speed-up-time-to-patient\/","title":{"rendered":"Customer Story"},"content":{"rendered":"

\nWhat role can IT play in untangling increased trial complexity? Veeva\u2019s Stephan Ohnmacht and Thomas Dieffenbronn (global head of strategy, insights, and technology for global clinical operations at Novartis) discuss how technology strategy in life sciences should strike a balance between quick fixes and innovation, and why simplicity holds the key to speeding up.\n<\/p>\n

\nContact the Veeva Business Consulting team<\/a> to learn more about realizing the value of your technology investments.<\/p>\n","protected":false},"excerpt":{"rendered":"

Thomas Dieffenbronn from Novartis discusses how technology strategy in the life sciences should balance quick fixes and innovation.<\/p>\n","protected":false},"featured_media":79632,"parent":0,"template":"","product-link-list":[],"class_list":["post-79265","customer-stories","type-customer-stories","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t